1. Author Correction: Integrated molecular subtyping defines a curable oligometastatic state in colorectal liver metastasis. Issue 1 (December 2018) Authors: Pitroda, Sean; Khodarev, Nikolai; Huang, Lei; Uppal, Abhineet; Wightman, Sean; Ganai, Sabha; Joseph, Nora; Pitt, Jason; Brown, Miguel; Forde, Martin; Mangold, Kathy; Xue, Lai; Weber, Christopher; Segal, Jeremy; Kadri, Sabah; Stack, Melinda; Khan, Sajid; Paty, Philip; Kaul, Karen; Andrade, Jorge Journal: Nature communications Issue: Volume 9:Issue 1(2018) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Integrating a Large Next-Generation Sequencing Panel into the Clinical Diagnosis of Gliomas Provides a Comprehensive Platform for Classification from FFPE Tissue or Smear Preparations. Issue 3 (28th January 2019) Authors: Parilla, Megan; Kadri, Sabah; Patil, Sushant A; Fitzpatrick, Carrie; Ritterhouse, Lauren; Segal, Jeremy; Collins, John; Pytel, Peter Journal: Journal of neuropathology and experimental neurology Issue: Volume 78:Issue 3(2019) Page Start: 257 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Clinical outcomes of IDH2‐mutated advanced‐phase Ph‐negative myeloproliferative neoplasms treated with enasidenib. (1st May 2020) Authors: Patel, Anand A.; Cahill, Kirk; Charnot‐Katsikas, Angella; Liu, Hongtao; Gurbuxani, Sandeep; Thirman, Michael; Kosuri, Satyajit; Artz, Andrew S.; Larson, Richard A.; Stock, Wendy; Segal, Jeremy; Odenike, Olatoyosi Journal: British journal of haematology Issue: Volume 190:Number 1(2020) Page Start: e48 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Eosinophilic Renal Cell Tumors With a TSC and MTOR Gene Mutations Are Morphologically and Immunohistochemically Heterogenous: Clinicopathologic and Molecular Study. (July 2020) Authors: Tjota, Melissa; Chen, Heather; Parilla, Megan; Wanjari, Pankhuri; Segal, Jeremy; Antic, Tatjana Journal: American journal of surgical pathology Issue: Volume 44:Number 7(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Identification of Molecular Alterations Challenging Initial Pathologic Classification in Cases of Clinician-Initiated Next-Generation Sequencing Testing. Issue 6 (23rd June 2021) Authors: Cho, Joseph H; Charnot-Katsikas, Angela; Segal, Jeremy; Pytel, Peter Journal: American journal of clinical pathology Issue: Volume 156:Issue 6(2021) Page Start: 1007 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Aggressive morphologic variants of mantle cell lymphoma characterized with high genomic instability showing frequent chromothripsis, CDKN2A/B loss, and TP53 mutations: A multi‐institutional study. Issue 8 (17th April 2020) Authors: Streich, Lukas; Sukhanova, Madina; Lu, Xinyan; Chen, Yi‐Hua; Venkataraman, Girish; Mathews, Stephanie; Zhang, Shanxiang; Kelemen, Katalin; Segal, Jeremy; Gao, Juehua; Gordon, Leo; Chen, Qing; Behdad, Amir Journal: Genes, chromosomes & cancer Issue: Volume 59:Issue 8(2020) Page Start: 484 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Feasibility and limitations of cultured skin fibroblasts for germline genetic testing in hematologic disorders. Issue 7 (14th April 2022) Authors: DeRoin, Lia; Cavalcante de Andrade Silva, Marcela; Petras, Kristin; Arndt, Kelly; Phillips, Nathaniel; Wanjari, Pankhuri; Subramanian, Hari Prasanna; Montes, David; McElherne, James; Theissen, Megan; Briese, Renee; Das, Soma; Godley, Lucy A.; Segal, Jeremy; del Gaudio, Daniela; Fitzpatrick, Carri... Journal: Human mutation Issue: Volume 43:Issue 7(2022) Page Start: 950 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. NPM1 exon 5 mutations in acute myeloid leukemia: Implications in diagnosis and minimal residual monitoring. Issue 3 (26th April 2022) Authors: Wang, Peng; Segal, Jeremy; Drazer, Michael W.; Venkataraman, Girish; Arber, Daniel A.; Gurbuxani, Sandeep Journal: EJHaem Issue: Volume 3:Issue 3(2022) Page Start: 962 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. MUC4 expression by immunohistochemistry is a specific marker for BCR-ABL1+ and BCR-ABL1-like B-lymphoblastic leukemia. Issue 6 (12th May 2022) Authors: Kaumeyer, Benjamin; Fidai, Shiraz; Sukhanova, Madina; Yap, Kai Lee; Segal, Jeremy; Raca, Gordana; Stock, Wendy; McNeer, Jennifer; Lager, Angela M.; Gurbuxani, Sandeep Journal: Leukemia & lymphoma Issue: Volume 63:Issue 6(2022) Page Start: 1436 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Therapy‐related myeloid neoplasms with normal karyotype show distinct genomic and clinical characteristics compared to their counterparts with abnormal karyotype. (18th March 2022) Authors: Tariq, Hamza; Barnea Slonim, Liron; Coty Fattal, Zachary; Alikhan, Mir B.; Segal, Jeremy; Gurbuxani, Sandeep; Helenowski, Irene B.; Zhang, Hui; Sukhanova, Madina; Lu, Xinyan; Altman, Jessica K.; Chen, Qing C.; Behdad, Amir Journal: British journal of haematology Issue: Volume 197:Number 6(2022) Page Start: 736 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗